The FDA-authorized Metrix COVID/Flu molecular test detects and differentiates COVID, Flu A, and B in 20 minutes. It may be used in home and CLIA-waived settings. SANTA BARBARA, Calif., Feb. 24, 2025 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA issued an emergency use authorization for CorDx ...
The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 ...
LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete assay receives Emergency Use Authorization from the FDA along with being successfully validated by the UK Health Security Agency (UKHSA) under the ...
A team of scientists at NYU Abu Dhabi has developed a breakthrough paper-based diagnostic device that can detect COVID-19 and other infectious diseases in under 10 minutes, without the need for ...
Medical Device Network on MSN
LEX Diagnostics secures FDA clearance for VELO PCR system
The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.
The Acceleration Round is intended to support commercial rollout, regulatory progress, further clinical validation, and ...
Breaking out the tissues? It's that time of year! But what kind of sickness do your symptoms point to? As the weather changes, we can start feeling under the weather too — but while each illness has a ...
SANTA BARBARA, Calif., Feb. 24, 2025 /PRNewswire/ — Aptitude Medical Systems, Inc. (Aptitude) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results